2024
Nivolumab plus relatlimab and nivolumab plus ipilimumab for patients with advanced renal cell carcinoma: results from the open-label, randomised, phase II FRACTION-RCC trial., T K Choueiri, T M Kuzel, S S Tykodi, E Verzoni, H Kluger, Suresh G. Nair MD, R Perets, S George, H Gurney, R K Pachynski, E Folefac, V Castonguay, C-H Lee, U Vaishampayan, W H Miller, P Bhagavatheeswaran, Y Wang, S Gupta, H DeSilva, C-W Lee, B Escudier, and R J Motzer (Article)
A Case of μ Heavy and λ Light Chain Amyloidosis in a Patient With Bi-Clonal (IgM κ and λ) Gammopathy Treated With Daratumumab., Armaan Dhaliwal MD, Ashish Tripathi, and Soumiya Ravi (Article)
SARS-CoV-2 vaccination in the first year after hematopoietic cell transplant or chimeric antigen receptor T cell therapy: A prospective, multicenter, observational study., Joshua A Hill, Michael J Martens, Jo-Anne H Young, Kavita Bhavsar, Jianqun Kou, Min Chen, Lik Wee Lee, Aliyah Baluch, Madhav V Dhodapkar, Ryotaro Nakamura, Kristin Peyton, Dianna S Howard, Uroosa Ibrahim, Zainab Shahid, Paul Armistead, Peter Westervelt, John McCarty, Joseph McGuirk, Mehdi Hamadani, Susan DeWolf, Kinga Hosszu, Elad Sharon, Ashley Spahn, Amir Toor MD, Stephanie Waldvogel, Lee M Greenberger, Jeffery J Auletta, Mary M Horowitz, Marcie L Riches, and Miguel-Angel Perales (Article)
Rituximab-Associated Liver Toxicity Without Known Viral Reactivation., Taha Huda; Fawaz Hussain; Hariharasudan Mani MD; Shereen M F Gheith MD, PhD; and Savitri Skandan MD (Article)
Evaluation of Patients Admitted to the Hospital with Sepsis, Febrile Neutropenia, or Pneumonia Following Administration of Chemotherapy, Abigail Kennedy; Savitri Skandan MD; Dennis Sopka MD; and Melissa Kratz RN, MSN, AOCN (Poster)
Subcutaneous epcoritamab (SC epcor) administered outpatient (outpt) for relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL): Results from phase 2 EPCORE NHL-6, Bradley Lash (Article)
A Rare Case of Duodenal Adenocarcinoma With Brain Metastasis., Hariharasudan Mani MD, Alisha Hossain DO, Elsie S. Lee MD, and Muhammad A. Rizvi MD (Article)
Retrospective Study of Unresectable Stage III or Stage IV Melanoma Patients Refractory to Immune Check Point and BRAF/MEK Inhibitors, Treated with Triplet Therapy: A Single Institution Experience., Hariharasudan Mani MD; Suresh G. Nair MD; Timothy Johnson MD; Darshan Lal MD; Zeeshan Hafeez MD; Hope Kincaid MPH, CPH; Alyson McIntosh MD; and Aaron U. Blackham MD (Presentation)
5-FU Mediated Coronary Vasospasm Leading to Stress Cardiomyopathy, Merissa Misiura MD, Amogh M. Joshi DO, Noah Dessalegn MD, Muhammad Aamir MD, Nicholas Lamparella DO, and Ronak Patel MD (Poster)
Adjuvant Nivolumab for Localized Renal Cell Carcinoma at High Risk of Recurrence After Nephrectomy: Part B of the Randomized, Placebo-Controlled, Phase III CheckMate 914 Trial., Robert J Motzer, Axel Bex, Paul Russo, Yoshihiko Tomita, Hernan Javier Cutuli, Carlos Rojas, Marine Gross-Goupil, Giovanni Schinzari, Bohuslav Melichar, Philippe Barthélémy, Abraham Ruiz Garcia, Jeffrey Sosman, Marc-Oliver Grimm, Jeffrey C Goh, Cristina Suarez, Christian K Kollmannsberger, Suresh G. Nair MD, Brian M Shuch, Jian Huang, Burcin Simsek, Julia Spiridigliozzi, Chung-Wei Lee, Maximiliano van Kooten Losio, and Viktor Grünwald (Article)
A phase 2 trial of IO102-IO103 and nivolumab-relatlimab fixed-dose combination in previously untreated, unresectable melanoma, Suresh G. Nair MD (Article)
Evaluating Lehigh Valley Health Network's Stage 1A Lung Cancer Care in Concordance with National Guidelines, Katie O'Connor; Melissa Kratz RN, MSN, AOCN; Savitri Skandan MD; and Dennis Sopka MD (Poster)
An epidemiologic study comparing cancer- and noncancer-associated venous thromboembolism in a racially diverse Southeastern United States county., Andrew M Peseski, Sargam Kapoor, Maragatha Kuchibhatla, Alys Adamski, Karon Abe, Michele G Beckman, Nimia L Reyes, Lisa C Richardson, Ibrahim Saber, Ryan Schulteis, Bhavana Pendurthi Singh MD, Andrea Sitlinger, Elizabeth H Thames, and Thomas L Ortel (Article)
Intravascular large B-cell lymphoma masquerading as stroke successfully treated with R-Hyper-CVAD., Christopher Popiolek, Kanchan Gupta, Mallorie L. Huff, and Ranju Gupta MD (Article)
Osimertinib-Induced Myositis in a Patient With Metastatic Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutation., Aatma Ram MD, Chun Siu, Abir Mukherjee MD, and Ranju Gupta MD (Article)
Early on-treatment assessment of T-cells, cytokines and tumor DNA with adaptively-dosed nivolumab + ipilimumab: final results from the phase 2 ADAPT-IT study., James W Smithy, Hannah L Kalvin, Fiona D Ehrich, Ronak Shah, Matthew Adamow, Vladislav Raber, Colleen A Maher, Jenna Kleman, Debra A G McIntyre, Alexander N Shoushtari, Allison Betof Warner, Margaret K Callahan, Parisa Momtaz, Omar Eton, Suresh G. Nair MD, Jedd D Wolchok, Paul B Chapman, Michael F Berger, Katherine S Panageas, and Michael A Postow (Article)
2023
Validation of Immunotherapy Response Score as Predictive of Pan-solid Tumor Anti-PD-1/PD-L1 Benefit., Benjamin J Bulen, Nickolay A Khazanov, Daniel H Hovelson, Laura E Lamb, Marc Matrana, Mark E Burkard, Eddy Shih-Hsin Yang, William J Edenfield, Elizabeth Claire Dees, Adedayo A Onitilo, Gary L Buchschacher, Alan M Miller, Benjamin M Parsons, Timothy R Wassenaar, Jennifer M Suga, Robert D Siegel, William Irvin, Suresh G. Nair MD, Jennifer N Slim, Jamal Misleh, Jamil Khatri, Gregory A Masters, Sachdev Thomas, Malek M Safa, Daniel M Anderson, Jonathan Mowers, Anna C Dusenbery, Stephanie Drewery, Komal Plouffe, Travis Reeder, Hana Vakil, Lynnae Patrias, Amanda Falzetta, Ryan Hamilton, Kat Kwiatkowski, D Bryan Johnson, Daniel R Rhodes, and Scott A Tomlins (Article)
Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma., Jonathan A Coleman, Wesley Yip, Nathan C Wong, Daniel D Sjoberg, Bernard H Bochner, Guido Dalbagni, S Machele Donat, Harry W Herr, Eugene K Cha, Timothy F Donahue, Eugene J Pietzak, A Ari Hakimi, Kwanghee Kim, Hikmat A Al-Ahmadie, H Alberto Vargas, Ricardo G Alvim, Soleen Ghafoor, Nicole E Benfante, Anoop M Meraney, Steven J Shichman, Jeffrey M Kamradt, Suresh G. Nair MD, Angelo A. Baccala MD, Paul Palyca MD, Bradley Lash MD, Muhammad A. Rizvi MD, Scott K Swanson, Antonio F Muina, Andrea B Apolo, Gopa Iyer, Jonathan E Rosenberg, Min Y Teo, and Dean F Bajorin (Article)
Engraftment syndrome after allogeneic stem cell transplantation: a systematic review and meta-analysis., Ghada ElGohary; Amir Toor MD; and Usama Gergis MD, MBA (Article)
EP04.02-04 Screening Success: A Review of Outcomes from Lehigh Valley Health Network’s Multi-Disciplinary Lung Cancer Screening Program, Eliot L. Friedman MD, Timothy Johnson MD, Andrea Dally CRNP, Kenneth Cavorsi MD, Richard S. Chang MD, Dennis Sopka MD, C. Gerard Petersen MD, Frank Sperrazza DO, and Dylan Soller DO (Article)
High dose valacyclovir for cytomegalovirus prophylaxis following allogeneic hematopoietic cell transplantation., Kelly G Hawks, Amanda Fegley, Roy T Sabo, Catherine H Roberts, and Amir Toor MD (Article)
SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational study., Joshua A Hill, Michael J Martens, Jo-Anne H Young, Kavita Bhavsar, Jianqun Kou, Min Chen, Lik Wee Lee, Aliyah Baluch, Madhav V Dhodapkar, Ryotaro Nakamura, Kristin Peyton, Zainab Shahid, Paul Armistead, Peter Westervelt, John McCarty, Joseph McGuirk, Mehdi Hamadani, Susan DeWolf, Kinga Hosszu, Elad Sharon, Ashley Spahn, Amir Toor MD, Stephanie Waldvogel, Lee M Greenberger, Jeffery J Auletta, Mary M Horowitz, Marcie L Riches, and Miguel-Angel Perales (Article)
Plasmacytic neoplasm in a patient with chronic Immunosuppression: an unusual clinical presentation as shoulder mass, Alisha Hossain DO, Emily C. Skutnik DO, Rayna Abraham, Robert V. Decker MD, Mini G. Abraham MD, and Eliot L. Friedman MD (Poster)
Analysis of Systems of Care and Outcomes for Stage III Melanoma Patients at Lehigh Valley Topper Cancer Institute (2014-2019), Aidan Johnson and Suresh G. Nair MD (Poster)
Improved Overall Well-Being After Breast Conserving Therapy Using Three-Dimensional Bioabsorbable Markers and Tissue Rearrangement, a Single Institution's Preliminary Experience., Rebecca M Jordan, Monica Rebielak, Kelly Johnson, Marcus Fluck, and Jacqueline Oxenberg DO (Article)
207P Palbociclib (P) in patients (pts) with solid tumors with CDK4 or CDK6 amplification (amp): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study, Maged Khalil MD, M Rothe, P K. Mangat, E Garrett- Mayer, K F. Mileham, E R. Ahn, H L. Duvivier, L C. Farrington, M Akce, D Behl, P J. Gold, V K. Chiu, N Vijayvergia, C Calfa, A Gaba, F Meric-Bernstam, S M. Schetze, A Gregory, S Halabi, and R L. Schilsky (Article)
Immunotherapy May Improve Tumor Sensitivity to Palliative Chemotherapy in Platinum Resistant Ovarian Cancer., Rachel Kinney DO, Suresh G. Nair MD, Christine H. Kim MD, M Bijoy Thomas MD, and Martin DelaTorre DO (Article)
Brain Metastases With Malignant Peritoneal Mesothelioma: Never Reported Before., Darshan Lal MD, Merissa Misiura MD, Waqas Adeel, and Rizwan Tariq MD (Article)
The Correlation of Thyroid Hormone Levels and Anti-Thyroidal Drugs on Thyroid Size, Weight, and Ease of Surgical Dissection for Thyroidectomy for Graves' Disease., Kelcie Lushefski MD, Mary Wolf, James Dove, Marcus Fluck, and Jacqueline Oxenberg DO (Article)
Genetic Referrals, Appointments and Testing for BRCA Mutation in Ovarian Cancer Patients from 2019 to 2022, Julia Mandarino; Melissa Kratz RN, MSN, AOCN; Samantha Carr MS, LGCG; Savitri Skandan MD; and Christine H. Kim MD (Poster)
Physician knowledge, practice patterns, and barriers encountered regarding guideline-concordant use of bone modifying agents for prostate cancer., Aaron P Mitchell, Sonia Persaud, Paul Palyca MD, Andrew Salner, Azeez Farooki, Jamie S Ostroff, Michael J Morris, and Susan Chimonas (Article)
Barriers to guideline-concordant use of bone modifying agents for prostate cancer., A P. Mitchell, S Persaud, S Chimonas, A Salner, Paul Palyca MD, A Farooki, J Ostroff, and M J. Morris (Article)
Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial., Farshad Nassiri, Vikas Patil, Leeor S Yefet, Olivia Singh, Jeff Liu, Rachel M A Dang, Takafumi N Yamaguchi, Mariza Daras, Timothy F Cloughesy, Howard Colman, Priya U Kumthekar, Clark C Chen, Robert Aiken, Morris D Groves, Shirley S Ong, Rohan Ramakrishna, Michael A Vogelbaum, Simon Khagi, Thomas Kaley, Jason M Melear, David M Peereboom, Analiz Rodriguez, Maxim Yankelevich, Suresh G. Nair MD, Vinay K Puduvalli, Kenneth Aldape, Andrew Gao, Álvaro López-Janeiro, Carlos E de Andrea, Marta M Alonso, Paul Boutros, Joan Robbins, Warren P Mason, Adam M Sonabend, Roger Stupp, Juan Fueyo, Candelaria Gomez-Manzano, Frederick F Lang, and Gelareh Zadeh (Article)
Randomized, phase II, placebo-controlled trial of nintedanib for the treatment of radiation pneumonitis., Andreas Rimner, Zachary R Moore, Stephanie Lobaugh, Alexander Geyer, Daphna Y Gelblum, Raja-Elie E Abdulnour, Annemarie F Shepherd, Narek Shaverdian, Abraham J Wu, John Cuaron, Jamie E Chaft, Marjorie G Zauderer, Juliana Eng, Gregory J Riely, Charles M Rudin, Nicholas Vander Els, Mohit Chawla, Megan McCune, Henry Li, David R Jones, Dennis Sopka MD, Charles B Simone, Raymond Mak, Gerald L Weinhouse, Zhongxing Liao, Daniel R Gomez, Zhigang Zhang, and Paul K Paik (Article)
The Efficacy of Axillary Reverse Mapping for the Prevention of Lymphedema., Amanda E Ruffino, Joshua D Madera, Makayla M Dearborn, Katie Frank, and Jacqueline Oxenberg DO (Article)
Development and validation of an integrative pan-solid tumor predictor of PD-1/PD-L1 blockade benefit., Scott A Tomlins, Nickolay A Khazanov, Benjamin J Bulen, Daniel H Hovelson, Melissa J Shreve, Laura E Lamb, Marc R Matrana, Mark E Burkard, Eddy Shih-Hsin Yang, William Jeffery Edenfield, E Claire Dees, Adedayo A Onitilo, Michael Thompson, Gary L Buchschacher, Alan M Miller, Alexander Menter, Benjamin Parsons, Timothy Wassenaar, Leon C Hwang, J Marie Suga, Robert Siegel, William Irvin, Suresh G. Nair MD, Jennifer N Slim, Jamal Misleh, Jamil Khatri, Gregory Masters, Sachdev Thomas, Malek Safa, Daniel M Anderson, Kat Kwiatkowski, Khalis Mitchell, Tina Hu-Seliger, Stephanie Drewery, Andrew Fischer, Komal Plouffe, Eric Czuprenski, Jennifer Hipp, Travis Reeder, Hana Vakil, D Bryan Johnson, and Daniel R Rhodes (Article)
Cell-free next-generation sequencing impacts diagnosis and antimicrobial therapy in immunocompromised hosts: A retrospective study., Nicole C Vissichelli, Megan K Morales, Bharadhwaj Kolipakkam, Alexandra Bryson, Roy T Sabo, and Amir Toor MD (Article)
Allogeneic haematopoietic cell transplants as dynamical systems: influence of early-term immune milieu on long-term T-cell recovery., Viktoriya Zelikson, Roy Sabo, Myrna Serrano, Younus Aqeel, Savannah Ward, Taha Al Juhaishi, May Aziz, Elizabeth Krieger, Gary Simmons, Catherine Roberts, Jason Reed, Gregory Buck, and Amir Toor MD (Article)
2022
TKIs beyond immunotherapy predict improved survival in advanced HCC., Samantha Armstrong, Tina Roy, Bhavana Pendurthi Singh MD, Monika Kulasekaran, Fatima Shaukat, Xue Geng, Hongkun Wang, Petra Prins, Reena C Jha, Marion L Hartley, and Aiwu Ruth He (Article)
Risk stratification after recurrence of human papillomavirus (HPV)-related and non-HPV-related oropharyngeal cancer: Secondary analysis of NRG Oncology RTOG 0129 and 0522., Elaine O Bigelow, Jonathan Harris, Carole Fakhry, Maura L Gillison, Phuc Felix Nguyen-Tân, David I Rosenthal, Steven J Frank, Suresh G. Nair MD, Houda Bahig, John A Ridge, Jimmy Caudell, Craig Donaldson, Bradley T Clifford, George Shenouda, Michael J Birrer, Yuhchyau Chen, and Quynh-Thu Le (Article)
Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic, Priscilla K Brastianos, Erin L Twohy, Elizabeth R Gerstner, Timothy J Kaufmann, A John Iafrate, Jochen Lennerz, Suriya Jeyapalan, David E Piccioni, Varun Monga, Camilo E Fadul, David Schiff, Jennie W Taylor, Sajeel A Chowdhary, Chetan Bettegowda, George Ansstas, Macarena De La Fuente, Mark D Anderson, Nicole Shonka, Denise Damek, Jose Carrillo, Lara J Kunschner-Ronan, Rekha Chaudhary, Kurt A Jaeckle, Francis M Senecal, Thomas Kaley, Tara Morrison MD, Alissa A Thomas, Mary R Welch, Fabio Iwamoto, David Cachia, Adam L Cohen, Shivangi Vora, Michael Knopp, Ian F Dunn, Priya Kumthekar, Jann Sarkaria, Susan Geyer, Xiomara W Carrero, Maria Martinez-Lage, Daniel P Cahill, Paul D Brown, Caterina Giannini, Sandro Santagata, Frederick G Barker, and Evanthia Galanis (Article)
Deep Margins Melanoma: How Deep Is Deep Enough?, Megan L Burger, James M Haggerty, Shengxuan Wang, and Jacqueline Oxenberg DO (Article)
FRACTION-RCC: nivolumab plus ipilimumab for advanced renal cell carcinoma after progression on immuno-oncology therapy., Toni K Choueiri, Harriet Kluger, Saby George, Scott S Tykodi, Timothy M Kuzel, Ruth Perets, Suresh G. Nair MD, Giuseppe Procopio, Michael A Carducci, Vincent Castonguay, Edmund Folefac, Chung-Han Lee, Sebastien J Hotte, Wilson H Miller, Shruti Shally Saggi, Chung-Wei Lee, Heshani Desilva, Prabhu Bhagavatheeswaran, Robert J Motzer, and Bernard Escudier (Article)
Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial., Samuel A Funt, Michael Lattanzi, Karissa Whiting, Hikmat Al-Ahmadie, Colleen Quinlan, Min Yuen Teo, Chung-Han Lee, David Aggen, Danielle Zimmerman, Deaglan McHugh, Arlyn Apollo, Trey D Durdin, Hong Truong, Jeffrey Kamradt, Maged Khalil MD, Bradley Lash, Irina Ostrovnaya, Asia S McCoy, Grace Hettich, Ashley Regazzi, Marwah Jihad, Neha Ratna, Abigail Boswell, Kaitlyn Francese, Yuanquan Yang, Edmund Folefac, Harry W Herr, S Machele Donat, Eugene Pietzak, Eugene K Cha, Timothy F Donahue, Alvin C Goh, William C Huang, Dean F Bajorin, Gopa Iyer, Bernard H Bochner, Arjun V Balar, Amir Mortazavi, and Jonathan E Rosenberg (Article)
Multidisciplinary Treatment of Non-Spine Bone Metastases: Results of a Modified Delphi Consensus Process., Erin F Gillespie, Noah J Mathis, Max Vaynrub, Ernesto Santos Martin, Rupesh Kotecha, Joseph Panoff, Andrew L Salner, Alyson McIntosh MD, Ranju Gupta, Amitabh Gulati, Divya Yerramilli, Amy J Xu, Meredith Bartelstein, David M Guttmann, Yoshiya J Yamada, Diana Lin, Kaitlyn Lapen, Deborah Korenstein, David G Pfister, Allison Lipitz-Snyderman, and Jonathan T Yang (Article)
Pertuzumab Plus Trastuzumab in Patients With Colorectal Cancer With, Ranju Gupta MD, Funda Meric-Bernstam, Michael Rothe, Elizabeth Garrett-Mayer, Pam K Mangat, Stacy D'Andre, Eugene R Ahn, Raegan O'Lone, Susan Halabi, Gina N Grantham, and Richard L Schilsky (Article)
Best Processes for Development of a Successful Cardio-Oncology Program in a Community Hospital, Ranju Gupta MD; Deborah W Sundlof DO; Chun Siu DO; Kelly C. Schadler MSN, CRNP; Hannah Cooper; Simi Masand Rimi MD; Kailyn Mann DO; Janine Barnaby RPh, BCOP; Cheri Silverstein Fadlon MD; Paul S. Corotto MD; Nadeem V. Ahmad MD; and Ronald S. Freudenberger MD (Article)
A Retrospective Analysis of NRG/RTOG 0522: Low Myofibroblast Content in the Tumor-Associated Stroma may Predict Response to Epidermal Growth Factor Receptor (EGFR) Inhibitors, Y Haque, Y Cao, C E. Lominska, C H. Chung, A Pickard, A Bur, S Thomas, J Woodroof, E Yilmaz, P Neupane, D J. McCance, D I. Rosenthal, Suresh G. Nair MD, W L. Thorstad, A S. Garden, J J. Caudell, S Wong, J A. Bonner, J Harris, and G N. Gan (Article)
Trastuzumab Associated With Recurrent Severe Thrombocytopenia and Successful Use of Pertuzumab Monotherapy., Mallorie L Huff, Joshua A. Kalter MS3, Ramona E. Chase CRNP, and Ranju Gupta (Article)
Nivolumab plus ipilimumab (N+I) in patients (pts) with colorectal cancer (CRC) with high tumor mutational burden (hTMB): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study., Maged Khalil MD (Article)
Transient left ventricular dysfunction following chimeric antigen receptor T-cell-mediated encephalopathy: A form of stress cardiomyopathy., Adam Khorasanchi, Amir M Ansari, Wendy Bottinor, Gary Simmons, Antonio Abbate, and Amir Toor MD (Article)
The MEMORY Study: MulticentEr study of Minimally invasive surgery versus Open Radical hYsterectomy in the management of early-stage cervical cancer: Survival outcomes., Mario M Leitao; Qin C Zhou; Benny Brandt; Alexia Iasonos; Vasileios Sioulas; Katherine Lavigne Mager; Mark Shahin; Shaina Bruce; Destin R Black; Carrie G Kay; Meeli Gandhi; Maira Qayyum; Jennifer Scalici; Nathaniel L Jones; Rajesh Paladugu; Jubilee Brown; R Wendel Naumann; Monica D Levine; Alberto Mendivil; Peter C Lim; Elizabeth Kang; Leigh A Cantrell; Mackenzie W Sullivan; Martin A. Martino MD; Melissa Kratz RN, MSN, AOCN; Valentin Kolev; Shannon Tomita; Charles A Leath; Teresa K L Boitano; David W Doo; Colleen Feltmate; Ronan Sugrue; Alexander B Olawaiye; Ester Goldfeld; Sarah E Ferguson; Jessa Suhner; and Nadeem R Abu-Rustum (Article)
First-Line Nivolumab Plus Low-Dose Ipilimumab for Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Phase II CheckMate 142 Study., Heinz-Josef Lenz, Eric Van Cutsem, Maria Luisa Limon, Ka Yeung Mark Wong, Alain Hendlisz, Massimo Aglietta, Pilar García-Alfonso, Bart Neyns, Gabriele Luppi, Dana B Cardin, Tomislav Dragovich, Usman Shah MD, Sandzhar Abdullaev, Joseph Gricar, Jean-Marie Ledeine, Michael James Overman, and Sara Lonardi (Article)
Autoimmune Hemolytic Anemia and Pure Red Cell Aplasia Associated with Immunotherapy, Merissa Misiura MD, Martin DelaTorre DO, Natalie Chlus MD, Alisha Hossain DO, Muhammad A. Rizvi MD, and Suresh G. Nair MD (Poster)
DNA Methylation Research in Autologous Hematopoietic Stem Cell Transplant Population., Lathika Mohanraj, Dana M Lapato, Amir Toor MD, and Theresa Swift-Scanlan (Article)
Factors Affecting Quality of Life in Patients Receiving Autologous Hematopoietic Stem Cell Transplantation., Lathika Mohanraj, Lana Sargent, R K Elswick, Amir Toor MD, and Theresa Swift-Scanlan (Article)
DNA Methylation Changes in Autologous Hematopoietic Stem Cell Transplant Patients., Lathika Mohanraj, Hope Wolf, Scott Silvey, Jinze Liu, Amir Toor MD, and Theresa Swift-Scanlan (Article)
Updated clinical outcomes from ULI-EAP-100, an intermediate expanded access program for ulixertinib (BVD-523)., Suresh G. Nair MD (Article)
Global Circumferential and Radial Strain Among Patients With Immune Checkpoint Inhibitor Myocarditis., Thiago Quinaglia, Carlos Gongora, Magid Awadalla, Malek Z O Hassan, Amna Zafar, Zsofia D Drobni, Syed S Mahmood, Lili Zhang, Otavio R Coelho-Filho, Giselle A Suero-Abreu, Muhammad A. Rizvi MD, Gagan Sahni, Anant Mandawat, Eduardo Zatarain-Nicolás, Michael Mahmoudi, Ryan Sullivan, Sarju Ganatra, Lucie M Heinzerling, Franck Thuny, Stephane Ederhy, Hannah K Gilman, Supraja Sama, Sofia Nikolaidou, Ana González Mansilla, Antonio Calles, Marcella Cabral, Francisco Fernández-Avilés, Juan José Gavira, Nahikari Salterain González, Manuel García de Yébenes Castro, Ana Barac, Jonathan Afilalo, Daniel A Zlotoff, Leyre Zubiri, Kerry L Reynolds, Richard Devereux, Judy Hung, Michael H Picard, Eric H Yang, Dipti Gupta, Caroline Michel, Alexander R Lyon, Carol L Chen, Anju Nohria, Michael G Fradley, Paaladinesh Thavendiranathan, and Tomas G Neilan (Article)
Cutaneous Squamous Cell Carcinoma of the Nipple Presenting as Paget's Disease., Monica Rebielak, Mary Wolf, and Jacqueline Oxenberg DO (Article)
Racial differences in venous thromboembolism: A surveillance program in Durham County, North Carolina, Ibrahim Saber, Alys Adamski, Maragatha Kuchibhatla, Karon Abe, Michele Beckman, Nimia Reyes, Ryan Schulteis, Bhavana Pendurthi Singh MD, Andrea Sitlinger, Elizabeth Thames, and Thomas Ortel (Article)
Immunoscore Is Prognostic in Low-Risk and High-Risk Stage III Colon Carcinomas Treated With Adjuvant Infusional Fluorouracil, Leucovorin, and Oxaliplatin in a Phase III Trial., Frank A Sinicrope, Qian Shi, Aurelie Catteau, Graham M Poage, Tyler J Zemla, Bernhard Mlecnik, Al B Benson, Sharlene Gill, Richard M Goldberg, Morton S Kahlenberg, Suresh G. Nair MD, Anthony F Shields, Thomas C Smyrk, Jerome Galon, and Steven R Alberts (Article)
Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma., Hussein A Tawbi, Dirk Schadendorf, Evan J Lipson, Paolo A Ascierto, Luis Matamala, Erika Castillo Gutiérrez, Piotr Rutkowski, Helen J Gogas, Christopher D Lao, Juliana Janoski De Menezes, Stéphane Dalle, Ana Arance, Jean-Jacques Grob, Shivani Srivastava, Mena Abaskharoun, Melissa Hamilton, Sarah Keidel, Katy L Simonsen, Anne Marie Sobiesk, Bin Li, F Stephen Hodi, Georgina V Long, and Suresh G. Nair MD (Article)
Ewing Sarcoma of the 9th Rib Subsequent to Pediatric Leukemia: A Case Series., Julia Vandenheuvel MD, Leighton Elliott, Daniel Zinn MD, Michal Miller, and Jacob Troutman DO (Article)
Assessing the COVID-19 Pandemic's Impact on Breast Cancer Appointment Scheduling, Alan Van Tiggelen and Muhammad A. Rizvi MD (Poster)
Adjuvant enzalutamide for the treatment of early-stage androgen-receptor positive, triple-negative breast cancer: a feasibility study., Elaine M Walsh, Ayca Gucalp, Sujata Patil, Marcia Edelweiss, Dara S Ross, Pedram Razavi, Shanu Modi, Neil M Iyengar, Rachel Sanford, Tiffany Troso-Sandoval, Mila Gorsky, Jacqueline Bromberg, Pamela Drullinsky, Diana Lake, Serena Wong, Patricia Ann DeFusco, Nicholas Lamparella DO, Ranju Gupta, Tasmila Tabassum, Leigh Ann Boyle, Artavazd Arumov, and Tiffany A Traina (Article)
Durable Complete Remission With Combination of Stereotactic Body Radiation Therapy (SBRT) and Talimogene Laherparepvec (TVEC) Followed by Ipilimumab in Refractory Metastatic Melanoma, Zachary Wolfe MD, Aaron U. Blackham MD, Alyson McIntosh MD, Angela Miller RN, Hina A. Sheikh MD, and Suresh G. Nair MD (Article)
Case report: response to the ERK1/2 inhibitor ulixertinib in BRAF D594G cutaneous melanoma., Zachary Wolfe MD; Julie C Friedland; Sarah Ginn; Aaron U. Blackham MD; Lauren Demberger PA-C; Morgan M. Horton BSN, RN, CCRC; Alyson McIntosh MD; Hina A. Sheikh MD; Jessica Box; Deborah Knoerzer; Bryan Federowicz; Timothy J Stuhlmiller; Mark Shapiro; and Suresh G. Nair MD (Article)
Allogeneic Hematopoietic Cell Transplants as Dynamical Systems: Effect of Early-Term Immune Suppression Intensity on Long-Term T Cell Recovery, Viktoriya Zelikson, Roy Sabo, Myrna Serrano, Younus Aqeel, Savannah Ward, Taha Al Juhaishi, May Aziz, Elizabeth Krieger, Gary Simmons, Catherine Roberts, Jason Reed, Gregory Buck, and Amir Toor MD (Article)
Dynamical Systems Modeling of Early-Term Immune Reconstitution with Different Antithymocyte Globulin Administration Schedules in Allogeneic Stem Cell Transplantation., Viktoriya Zelikson, Gary Simmons, Natasha Raman, Elizabeth Krieger, Anatevka Rebiero, Kelly Hawks, May Aziz, Catherine Roberts, Alden Chesney, Jason Reed, Ronald Gress, and Amir Toor MD (Article)
2021
What is the minimum adequate busulfan dose for patients with sickle cell disease undergoing reduced intensity conditioning with fludarabine, busulfan, and anti-thymocyte globulin?, Naif I AlJohani and Amir Toor MD (Article)
Recombinant activated factor VII in a patient with intracranial hemorrhage and severe thrombocytopenia., Amir M Ansari, Adam Khorasanchi, Armaghan Faghihimehr, and Amir Toor MD (Article)
Vaccinating the unvaccinated adult., Dillon Cason MD and Paul Williams (Article)
The Impact of Telephonic Follow-Up Within 2 Business Days Postdischarge on 30-Day Readmissions for Patients With Heart Failure, Victoria Chestnut DNP, MBA, RN, CCCTM; Karen Vadyak; Matthew McCambridge MD; and Michael J. Weiss MPH (Article)
Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma., Toni K Choueiri, Thomas Powles, Mauricio Burotto, Bernard Escudier, Maria T Bourlon, Bogdan Zurawski, Victor M Oyervides Juárez, James J Hsieh, Umberto Basso, Amishi Y Shah, Cristina Suárez, Alketa Hamzaj, Jeffrey C Goh, Carlos Barrios, Martin Richardet, Camillo Porta, Rubén Kowalyszyn, Juan P Feregrino, Jakub Żołnierek, David Pook, Elizabeth R Kessler, Yoshihiko Tomita, Ryuichi Mizuno, Jens Bedke, Joshua Zhang, Matthew A Maurer, Burcin Simsek, Flavia Ejzykowicz, Gisela M Schwab, Andrea B Apolo, Robert J Motzer, and Suresh G. Nair MD (Article)
Hepatoid esophagogastric adenocarcinoma and tumoral heterogeneity: a case report., Tiago Biachi de Castria, Laura Tang, Marcello Moro Queiroz, Beatriz Mendes Awni, Viktoriya Paroder, Ali Shamseddine, Giovanni Mendonca Bariani, Deborah Mukherji, Charbel F Matar, Gustavo Dos Santos Fernandes, Ashwaq El-Olayan, Fouad Sabatin, Rawad Elias, Ranju Gupta MD, Yelena Y Janjigian, and Ghassan K Abou-Alfa (Article)
Precursor B- Cell Lymphoblastic Lymphoma, Saloni Goyal DO, Chun Siu DO, Robert V. Decker MD, Mini G. Abraham MD, Rayna Abraham, and Savitri Skandan MD (Poster)
Light chain cast nephropathy caused by plasmablastic lymphoma of the bladder, Mehrian Jafarizade, Kiran M. Goli, Vivette D'Agati, Essel Dulaimi, Krupa Daniel, Bradley Lash, and Sharon E. Maynard MD (Article)
Hyperhemolysis Syndrome in a Patient with Sickle Cell Disease: A Case Report., Joshua A. Kalter MS3; Ranju Gupta MD; Marna R. Greenberg DO, MPH, FACEP; Andrew J. Miller DO; and Jamie Allen DO (Article)
Gastric Antral Vascular Ectasia: Trends of Hospitalizations, Biodemographic Characteristics, and Outcomes With Watermelon Stomach., Asim Kichloo, Dhanshree Solanki, Jagmeet Singh, Dushyant Singh Dahiya, Darshan Lal MD, Khwaja Fahad Haq, Michael Aljadah, Darshan Gandhi, Shantanu Solanki, and Hafiz Muzaffar Akbar Khan (Article)
Neoadjuvant Immunotherapy in Microsatellite-Instability High Nonmetastatic Colorectal Cancer: A Single-institute Experience and Review of the Literature., Rachel Kinney DO and Maged Khalil MD (Article)
Correction: Increased donor inhibitory KIR with known HLA interactions provide protection from relapse following HLA matched unrelated donor HCT for AML., Elizabeth Krieger, Rehan Qayyum, Armand Keating, and Amir Toor MD (Article)
Increased donor inhibitory KIR with known HLA interactions provide protection from relapse following HLA matched unrelated donor HCT for AML., Elizabeth Krieger, Rehan Qayyum, Armand Keating, and Amir Toor MD (Article)
What You Need to Know About Breast Cancer, Lehigh Valley Health Network and Ranju Gupta MD (Podcast)
Prophylactic Negative Pressure Wound Therapy After Laparotomy for Gynecologic Surgery: A Randomized Controlled Trial., Mario M Leitao, Qin C Zhou, Maria B Schiavone, Renee A Cowan, Evan S Smith, Alexia Iasonos, Mitchell Veith, Michael Rafizadeh, Katherine Curran, Bhavani Ramesh, Kaity Chang, Dennis S Chi, Yukio Sonoda, Amy K Brown, Jonathan A Cosin, Nadeem R Abu-Rustum, Martin A. Martino MD, Jennifer J Mueller, Kara Long Roche, Elizabeth L Jewell, Vance Broach, Nicholas C Lambrou, John P Diaz, and Oliver Zivanovic (Article)
Multidisciplinary consensus recommendations for the management of non-spine bone metastases: Results of a modified Delphi process in a community-academic partnership., Alyson McIntosh MD and Ranju Gupta (Article)
Single cell biomass tracking allows identification and isolation of rare targeted therapy-resistant DLBCL cells within a mixed population., Graeme F Murray, Daniel Guest, Andrey Mikheykin, Amir Toor MD, and Jason Reed (Article)
Adaptive Dosing of Nivolumab + Ipilimumab Immunotherapy Based Upon Early, Interim Radiographic Assessment in Advanced Melanoma (The ADAPT-IT Study), Michael A. Postow, Debra A. Goldman, Alexander N. Shoushtari, Allison Betof Warner, Margaret K. Callahan, Parisa Momtaz, James W. Smithy, Ellesa Naito, Marina K. Cugliari, Vladislav Raber, Omar Eton, Suresh G. Nair MD, Katherine S. Panageas, Jedd D. Wolchok, and Paul B. Chapman (Article)
Acute Infusion-Related Reactions: How to Recognize and Intervene When These Reactions Occur in Practice, Maura Price RN, BSN, OCN (Article)
A Retrospective Review of LVHN Compliance With Diagnostic Workup For Pancreatic Cancer Per NCCN Guidelines, Caitlin Scialla; Dennis Sopka MD; Savitri Skandan MD; and Melissa Kratz RN, MSN, AOCN (Poster)
Therapeutic Implications of Detecting MAPK-Activating Alterations in Cutaneous and Unknown Primary Melanomas., Alexander N Shoushtari, Walid K Chatila, Arshi Arora, Francisco Sanchez-Vega, Havish S Kantheti, Jorge A Rojas Zamalloa, Penina Krieger, Margaret K Callahan, Allison Betof Warner, Michael A Postow, Parisa Momtaz, Suresh G. Nair MD, Charlotte E Ariyan, Christopher A Barker, Mary Susan Brady, Daniel G Coit, Neal Rosen, Paul B Chapman, Klaus J Busam, David B Solit, Katherine S Panageas, Jedd D Wolchok, and Nikolaus Schultz (Article)
Evaluation of thrombophilia testing in the inpatient setting: A single institution retrospective review, Chun Siu, Zachary Wolfe, Martin DelaTorre, Erafat Rehim, Robert V. Decker MD, Kathryn Zaffiri MPH, and Bradley Lash (Article)
Myocardial T1 and T2 Mapping by Magnetic Resonance in Patients With Immune Checkpoint Inhibitor-Associated Myocarditis., Paaladinesh Thavendiranathan, Lili Zhang, Amna Zafar, Zsofia D Drobni, Syed S Mahmood, Marcella Cabral, Magid Awadalla, Anju Nohria, Daniel A Zlotoff, Franck Thuny, Lucie M Heinzerling, Ana Barac, Ryan J Sullivan, Carol L Chen, Dipti Gupta, Michael C Kirchberger, Sarah E Hartmann, Jonathan W Weinsaft, Hannah K Gilman, Muhammad A. Rizvi MD, Bojan Kovacina, Caroline Michel, Gagan Sahni, Ana González-Mansilla, Antonio Calles, Francisco Fernández-Avilés, Michael Mahmoudi, Kerry L Reynolds, Sarju Ganatra, Juan José Gavira, Nahikari Salterain González, Manuel García de Yébenes Castro, Raymond Y Kwong, Michael Jerosch-Herold, Otavio R Coelho-Filho, Jonathan Afilalo, Eduardo Zataraín-Nicolás, A John Baksi, Bernd J Wintersperger, Oscar Calvillo-Arguelles, Stephane Ederhy, Eric H Yang, Alexander R Lyon, Michael G Fradley, and Tomas G Neilan (Article)
Real-World Performance of a Comprehensive Genomic Profiling Test Optimized for Small Tumor Samples, Scott A. Tomlins, Daniel H. Hovelson, Jennifer M. Suga, Daniel M. Anderson, Han A. Koh, Elizabeth C. Dees, Brendan McNulty, Mark E. Burkard, Michael Guarino, Jamil Khatri, Malek M. Safa, Marc R. Matrana, Eddy S. Yang, Alex R. Menter, Benjamin M. Parsons, Jennifer N. Slim, Michael A. Thompson, Leon Hwang, William J. Edenfield, and Suresh G. Nair MD (Article)
Anti-Cancer Treatment Strategies in the Older Population: Time to Test More?, Antonino C Tralongo, Roberto S Fratamico MD, Chiara Russo, Andrea Sbrana, Andrea Antonuzzo, and Marco Danova (Article)
Orthostatic intolerance syndromes after hematopoietic cell transplantation: clinical characteristics and therapeutic interventions in a single-center experience., Alessandra Vecchié, Georgia Thomas, Edoardo Bressi, Aldo Bonaventura, Justin M Canada, David Chuquin, Dinesh Kadariya, Usman Piracha, Delia Endicott, Roshanak Markley, Amir Toor MD, Michael Hess, and Antonio Abbate (Article)
Multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART), Michael J. Wagner, Megan Othus, Sandip P. Patel, Chris Ryan, Ashish Sangal, Benjamin Powers, G Thomas Budd, Adrienne I. Victor, Chung-Tsen Hsueh, Rashmi Chugh, Suresh G. Nair MD, Kirsten M. Leu, Mark Agulnik, Elad Sharon, Edward Mayerson, Melissa Plets, Charles Blanke, Howard Streicher, Young Kwang Chae, and Razelle Kurzrock (Article)
Induction versus no induction chemotherapy before neoadjuvant chemoradiotherapy and surgery in oesophageal adenocarcinoma: a multicentre randomised phase II trial (NCCTG N0849 [Alliance]), Harry H. Yoon, Fang-Shu Ou, Gamini S. Soori, Qian Shi, Dennis A. Wigle, Robert P. Sticca, Robert Clell Miller, James L. Leenstra, Patrick J. Peller, Brenda Ginos, Erica Heying, Tsung-Teh Wu, Timothy F. Drevyanko, Stephen Ko, Bassam Ibrahim Mattar, Daniel A. Nikcevich, Robert J. Behrens, Maged Khalil MD, George P. Kim, and Steven R. Alberts (Article)
Dynamical Systems Modeling of Early-Term Immune Reconstitution with Different Anti-Thymocyte Globulin (ATG) Administration Schedules in Allogeneic Stem Cell Transplantation, Viktoriya Zelikson, Gary Simmons, Natasha Raman, Elizabeth Krieger, Anatevka Rebiero, Kelly Hawks, May Aziz, Catherine Roberts, Jason Reed, Ronald Gress, and Amir Toor MD (Article)